Geminin: A good prognostic factor in high-grade astrocytic brain tumors

Cancer

Volumn 109, Issue 5, 2007, Pages 949-956

  Shrestha, Prabin ^a   Saito, Taiichi ^a   Hama, Seiji ^a   Arifin, Muhamad T ^a   Kajiwara, Yoshinori ^a   Yamasaki, Fumiyuki ^a   Hidaka, Toshikazu ^a   Sugiyama, Kazuhiko ^a   Kurisu, Kaoru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Geminin; High grade astrocytoma; Immunohistochemistry; MIB 1

Indexed keywords

GEMININ; NUCLEAR PROTEIN; REPLICATION LICENSING FACTOR CDT1;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CHILD; DNA REPLICATION; EARLY CANCER; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33847387994     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22474     Document Type: Article

References (22)

1. Giangaspero F, Burger PC. Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 cases. Cancer. 1983;52:2320-2333.
2. Nishitani H, Lygerou Z. Control of DNA replication licensing in a cell cycle. Genes Cells. 2002;7:523-534.
3. Nishitani H, Taraviras S, Lygerou Z, Nishimoto T. The human licensing factor for DNA replication Cdt1 accumulates in G1 and is destabilized after initiation of S-phase. J Biol Chem. 2001;276:44905-44911.
4. Eward KL, Obermann EC, Shreeram S, et al. DNA replication licensing in somatic and germ cells. J Cell Sci. 2004;117(pt 24):5875-5886.
5. McGarry TJ, Kirschner MW. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell. 1998;93:1043-1053.
6. Hodgson B, Li A, Tada S, Blow JJ. Geminin becomes activated as an inhibitor of Cdt1/RLF-B following nuclear import. Curr Biol. 2002;12:678-683.
7. Yoshida K, Takisawa H, Kubota Y. Intrinsic nuclear import activity of geminin is essential to prevent re-initiation of DNA replication in Xenopus eggs. Genes Cells. 2005;10:63-73.
8. Quinn LM, Herr A, McGarry TJ, Richardson H. The Drosophila geminin homolog: roles for geminin in limiting DNA replication, in anaphase and in neurogenesis. Genes Dev. 2001;15:2741-2754.
9. Ballabeni A, Melixetian M, Zamponi R, Masiero L, Marinoni F, Helin K. Human geminin promotes pre-RC formation and DNA replication by stabilizing CDT1 in mitosis. EMBO J. 2004;23:3122-3132.
10. Kulartz M, Kreitz S, Hiller E, Damoc EC, Przybylski M, Knippers R. Expression and phosphorylation of the replication regulator protein geminin. Biochem Biophys Res Commun. 2003;305:412-420.
11. Bravou V, Nishitani H, Song SY, Taraviras S, Varakis J. Expression of the licensing factors, Cdt1 and geminin, in human colon cancer. Int J Oncol. 2005;27:1511-1518.
12. Wharton SB, Hibberd S, Eward KL, et al. DNA replication licensing and cell cycle kinetics of oligodendroglial tumors. Br J Cancer. 200419;91:262-269.
13. Montanari M, Boninsegna A, Faraglia B, et al. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors. J Cell Physiol. 2005;202:215-222.
14. Wohlschlegel JA, Kutok JL, Weng AP, Dutta A. Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am J Pathol. 2002;161:267-273.
15. Xouri G, Lygerou Z, Nishitani H, Pachnis V, Nurse R Taraviras S. Cdt1 and geminin are down-regulated upon cell cycle exit and are over-expressed in cancer-derived cell lines. Eur J Biochem. 2004;271:3368-3378.
16. Shetty A, Loddo M, Fanshawe T, et al. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer. 200528;93:1295-1300.
17. Gonzalez MA, Tachibana KE, Chin SE et al. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol. 2004;204:121-130.
18. Dudderidge TJ, Stoeber K, Loddo M, et al. Mcm2, geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res. 2005;11:2510-2517.
19. Ashby LS, Ryken TC. Management of malignant glioma: steady progress with multimodal approaches. Neurosurg Focus. 2006;20:E3.
20. Rainov NG, Soling A, Heidecke V. Novel therapies for malignant gliomas: a local affair? Neurosurg Focus. 2006;20:E9.
21. Hama S, Matsuura S, Tauchi H, et al. p16 Gene transfer increases cell killing with abnormal nucleation after ionising radiation in glioma cells. Br J Cancer. 2003;89:1802-1811
22. Terasima T, Tolmach LJ. Variations in several responses of HeLa cells to x-irradiation during the division cycle. Biophys J. 1963;3:11-33.